SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus
7 references·16 citing·27 second hop
Incidence of Recreational Use of 3,4-Methylenedimethoxymethamphetamine (MDMA, Ecstasy) on an Undergraduate Campus (1987)Incidence of Recreational Use of 3,4-Meth…Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Neurotoxicity of the psychede…Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Biochemical and histological …The Psychological and Physiological Effects of MDMA on Normal Volunteers (1986)The Psychological and Physiol…The Background and Chemistry of MDMA (1986)The Background and Chemistry …Subjective Reports of the Effects of MDMA in a Clinical Setting (1986)Subjective Reports of the Eff…Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue (1986)Methylenedioxymethamphetamine…Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals (1985)Hallucinogenic Amphetamine Se…Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects (2006)Neuroimaging findings with MD…Preliminary evidence of hippocampal dysfunction in adolescent MDMA (?ecstasy?) users: possible relationship to neurotoxic effects (2004)Preliminary evidence of hippo…The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers (2000)The serotonin uptake inhibito…Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study (2000)Effect of ecstasy [3,4-methyl…(±)-3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) increases social interaction in rats (2000)(±)-3,4-Methylenedioxymethamp…Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users (1999)Cerebral 1H MRS alterations i…Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat (1999)Behavioural analysis of the a…3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans (1999)3,4-Methylenedioxy analogues …Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations (1995)Psychobiologic effects of 3,4…Increasing Use of “Ecstasy“ (MDMA) and other Hallucinogens on a College Campus (1994)Increasing Use of “Ecstasy“ (…Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function? (1992)Chronic 3,4-Methylenedioxymet…‘Ecstasy’ Psychosis and Flashbacks (1991)‘Ecstasy’ Psychosis and Flash…Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (1990)Neurochemistry and Neurotoxic…Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observationsa (1990)Aminergic Metabolites in Cere…Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users (1989)Neuroendocrine and Mood Respo…Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) (1988)Serotonergic-dopaminergic med…Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)The health effects of ecstasy: a literature review (2002)The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) (2003)MDMA (3,4-Methylenedioxymethamphetamine) or Ecstasy: The Neuropsychobiological Implications of Taking It at Dances and Raves (2004)3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human Brain (2002)Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users (2003)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans (1994)Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP (2003)A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers (2006)Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline (2019)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study (2012)3,4-Methylenedioxymethamphetamine (Ecstasy) and Alcohol Interactions in Humans: Psychomotor Performance, Subjective Effects, and Pharmacokinetics (2002)Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)A review of the acute subjective effects of MDMA/ecstasy (2006)Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. (1988)Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat (1987)Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") (2001)Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat. (1996)The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents* (2006)Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research (2013)
this work references cited by second hop

References

  • 1987Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.530 cited
  • 1987Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.453 cited
  • 1986Subjective Reports of the Effects of MDMA in a Clinical Setting413 cited
  • 1985Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals367 cited
  • 1986The Background and Chemistry of MDMA233 cited
  • 1986The Psychological and Physiological Effects of MDMA on Normal Volunteers226 cited
  • 1986Methylenedioxymethamphetamine: A potentially neurotoxic amphetamine analogue202 cited

Cited by

  • 1990Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)183 cited
  • 19993,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans178 cited
  • 1995Psychobiologic effects of 3,4-methylenedioxymethamphetamine in humans: methodological considerations and preliminary observations175 cited
  • 1992Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?168 cited
  • 2000The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers144 cited
  • 2000Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

121 cited
  • 1988Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)117 cited
  • 2004Preliminary evidence of hippocampal dysfunction in adolescent MDMA (?ecstasy?) users: possible relationship to neurotoxic effects116 cited
  • 1991‘Ecstasy’ Psychosis and Flashbacks113 cited
  • 2000(±)-3,4-Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) increases social interaction in rats111 cited
  • 1999Cerebral 1H MRS alterations in recreational 3,4‐methylenedioxymethamphetamine (MDMA, “ecstasy”) users110 cited
  • 1999Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat101 cited
  • 1990Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observationsa101 cited
  • 1989Neuroendocrine and Mood Responses to Intravenous L-Tryptophan in 3,4-Methylenedioxymethamphetamine (MDMA) Users92 cited
  • 2006Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects85 cited
  • 1994Increasing Use of “Ecstasy“ (MDMA) and other Hallucinogens on a College Campus82 cited